Examples of using Secondary endpoints in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Key secondary endpoints included complete response(CR)
Secondary endpoints included progression-free survival(PFS), objective response rate(ORR),
Numerically greater responses compared with MTX alone were observed in the tocilizumab 8 mg/kg monotherapy group in all secondary endpoints, including radiographic endpoints. .
Secondary endpoints included the proportion of patients in clinical remission at week 4(CDAI<
Key secondary endpoints were OS in the ipilimumab+ gp100 group vs. the ipilimumab monotherapy group and in the ipilimumab
Results for secondary endpoints as tested in hierarchical order in the ITT analysis are displayed in Table 3.
sensitivity analyses of the primary endpoint and all secondary endpoints showed superiority of dabigatran etexilate over placebo.
Secondary Endpoints Changes from Baseline to Month 18 LSMean(Standard Error)(Intent- to-Treat Population) Study Fx-005.
Secondary endpoints were Progression-Free Survival(PFS), objective tumour response rate
The primary endpoint was PFS as assessed by central independent review; secondary endpoints included OS and ORR.
Temsirolimus also was associated with statistically significant advantages over IFN-α in the secondary endpoints of PFS, TTF, and clinical benefit rate.
were evaluable only for the secondary endpoints.
Mirabegron demonstrated statistically significant larger improvements compared to placebo for both co-primary endpoints as well as secondary endpoints see Tables 1 and 2.
for the primary and key secondary endpoints.
Mean changes from Baseline to end of treatment for primary and selected secondary endpoints.
Statistically significant superiority was also achieved in the key secondary endpoints of both major bleeding
The primary endpoint was overall survival, with secondary endpoints for the trial including progression-free survival.
Unfortunately the consecutive phase-III trial failed to show significant positive effects in the primary and secondary endpoints.
The primary endpoint was progression free survival, secondary endpoints for the trial included the duration of overall survival.
Secondary endpoints included time to objective disease progression,